TA Said to Revive Sale of $1 Billion Cosmetics Firm Vivacy (1)

Aug. 9, 2022, 4:27 PM UTC

TA Associates is reviving plans to sell French cosmetic treatment company Laboratoires Vivacy, people familiar with the matter said.

The buyout firm is working with BNP Paribas SA and Rothschild & Co. on a potential divestment that could value Vivacy at about 1 billion euros ($1 billion), the people said. It has drawn interest from Asian competitors and other private equity firms, according to the people, who asked not to be identified discussing confidential information.

Founded in 2007, Vivacy specializes in manufacturing injectable hyaluronic-acid dermal filler products, which are available in more than 75 countries, according to its website ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.